RWRobert A. Wilcox

Robert A. Wilcox

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert A. Wilcox has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Duplication within 14q32.13 implicates a chimeric CLMN :: SYNE3 RNA transcript in cerebellar ataxia

    by Thomas M Litster, Robert A Wilcox, Renée Carroll, Alison E Gardner, Nazzmer M Nazri, Cheryl A Shoubridge, Martin B Delatycki, Katja Lohmann, Marc Agzarian, Rafaela Turella Divani, et al.

    The spinocerebellar ataxias (SCAs) are a clinically heterogenous group of neurodegenerative disorders that affect movement, vision, speech and balance. Here, we reassign the linkage of SCA30 to 14q32.13 based on a cumulative LOD score >12. Within this interval we identified a 331 kb duplication, absent in population controls and not observed in >800 unrelated individuals with genetically unresolved cerebellar ataxia. RNA-Seq analysis of patient-derived lymphoblastoid cell lines revealed a splice-mediated chimeric transcript resulting from the duplication event. This transcript joined exon 1 of CLMN to exon 2 of SYNE3. In silico translation predicted that this chimeric transcript would produce a short N-terminal peptide corresponding to exon 1 of CLMN and the usually untranslated region of exon 2 of SYNE3 fused to the complete and in-frame SYNE3 protein. Transient overexpression of SYNE3 or the CLMN::SYNE3 fusion protein, in both HeLa cells and mouse primary cortical neurons, resulted in equivalent cellular outcomes including altered nuclear morphology and chromosomal DNA fragmentation. SYNE3 forms part of the linker of nucleoskeleton and cytoskeleton complex and is not usually expressed in cerebellar Purkyně neurons while, CLMN has a Purkyně specific expression pattern within the brain. Our data suggests that ectopic expression of SYNE3 in cerebellar Purkyně neurons, mediated by the CLMN promoter, leads to cerebellar atrophy and causes spinocerebellar ataxia in the SCA30 family. This is an example of Mendelian disease arising from a novel, chimeric transcript with a likely dominant negative effect. Chimeric transcripts are commonly associated with cancers, but they are not often associated with monogenic disorders. Detection of chimeric transcripts as part of structural variant analysis could increase the genetic diagnostic yield of Mendelian disorders.


  • Association between nigrosome-1 appearance on MRI and fine motor function in healthy adults and people living with Parkinson’s disease

    by Minh T. Chau, Marc Agzarian, Robert A. Wilcox, Gabrielle Todd

    One proposed MRI biomarker for Parkinson’s disease (PD) is the loss of hyperintense signal in nigrosome-1, a subregion of the dorsolateral substantia nigra pars compacta. However, little is known about the functional correlates of nigrosome-1 appearance on susceptibility-weighted MRI. This exploratory study investigated whether the area of the nigrosome-1 hyperintense signal is associated with fine motor performance in healthy adults and people living with PD. The cross-sectional study involved 95 healthy adults (aged 21–79 years) and 34 adults living with PD (aged 51–80 years). Participants completed an MRI, object grip and lift task, grooved pegboard test, maximal pinch grip voluntary contraction, maximal finger tapping, and tremor assessments. Predictors of fine motor performance were investigated with multilevel mixed-effects linear regression analysis. Area of nigrosome-1 hyperintense signal significantly predicted contralateral grooved pegboard performance (p = 0.001) in the healthy group, and contralateral maximum rate of change in grip force (object grip and lift task; p = 0.040) and ipsilateral tremor amplitude in the 3.9–6.6 Hz frequency range during a postural task (p = 0.050) in the PD group. Only one of these effects (grooved pegboard) survived correction for multiple comparisons. Expected between-group differences in area of nigrosome-1 hyperintense signal and fine motor performance were observed for participants aged 51–80 years (p ≤ 0.05). These findings suggest that area of nigrosome-1 hyperintense signal is associated with performance of some fine motor tasks in healthy adults and adults living with PD. The results of the current study inform interpretation of nigrosome-1 MRI findings in clinical settings.

  • Adults with a history of recreational cannabis use have altered speech production

    by Adam P. Vogel, Verity Pearson-Dennett, Michelle Magee, Robert A. Wilcox, Adrian Esterman, Dominic Thewlis, Jason M. White, Gabrielle Todd


  • History of cannabis use is associated with altered gait

    by Verity Pearson-Dennett, Gabrielle Todd, Robert A. Wilcox, Adam P. Vogel, Jason M. White, Dominic Thewlis


  • Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism

    by Gabrielle Todd, Verity Pearson-Dennett, Robert A. Wilcox, Minh T. Chau, Kerry Thoirs, Dominic Thewlis, Adam P. Vogel, Jason M. White


  • Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease)

    by Gabrielle Todd, Miranda Haberfield, Patrick L. Faulkner, Michael Hayes, Robert A. Wilcox, Caroline Rae, Tarsha Bulathsinhala, Ron R. Grunstein, Brendon J Yee, Kay L. Double


  • Open Access

    Hand Function is Altered in Individuals with a History of Illicit Stimulant Use

    by Verity Pearson-Dennett, Stanley C. Flavel, Robert A. Wilcox, Dominic Thewlis, Adam P. Vogel, Jason M. White, Gabrielle Todd

    Use of illicit stimulant drugs such as methamphetamine, cocaine, and ecstasy are a significant worldwide problem. However, little is known about the effect of these drugs on movement. The aim of the current study was to investigate hand function in adults with a history of illicit stimulant use. We hypothesized that prior use of illicit stimulant drugs is associated with abnormal manipulation of objects. The study involved 22 subjects with a history of illicit stimulant use (aged 29±8 yrs; time since last use: 1.8±4.0 yrs) and two control groups comprising 27 non-drug users (aged 25±8 yrs) and 17 cannabis users with no history of stimulant use (aged 22±5 yrs). Each subject completed screening tests (neuropsychological assessment, medical history questionnaire, lifetime drug history questionnaire, and urine drug screen) prior to gripping and lifting a light-weight object with the dominant right hand. Horizontal grip force, vertical lift force, acceleration, and first dorsal interosseus electromyographic (EMG) activity were recorded during three trials. In trial one, peak grip force was significantly greater in the stimulant group (12.8±3.9 N) than in the control groups (non-drug: 10.3±4.6 N; cannabis: 9.4±2.9 N, P<0.022). However, peak grip force did not differ between groups in trials two and three. The results suggest that individuals with a history of stimulant use overestimate the grip force required to manipulate a novel object but, are able to adapt grip force in subsequent lifts. The results suggest that movement dysfunction may be an unrecognized consequence of illicit stimulant use.


  • 3.

    by Kishore R. Kumar, Simon Weyers, Robert A. Wilcox, Jin S. Park, Aleksandar Rakovic, Christine Klein, Alan Mackay-Sim, Carolyn M. Sue

  • Hand function is impaired in healthy older adults at risk of Parkinson’s disease

    by Gabrielle Todd, Miranda Haberfield, Patrick L. Faulkner, Caroline Rae, Michael Hayes, Robert A. Wilcox, Janet L. Taylor, Simon C. Gandevia, Jana Godau, Daniela Berg, et al.

    Abnormal substantia nigra morphology in healthy individuals, viewed with transcranial ultrasound, is a significant risk factor for Parkinson’s disease. However, little is known about the functional consequences of this abnormality (termed ‘hyperechogenicity’) on movement. The aim of the current study was to investigate hand function in healthy older adults with (SN+) and without (SN−) substantia nigra hyperechogenicity during object manipulation. We hypothesised that SN+ subjects would exhibit increased grip force and a slower rate of force application compared to SN− subjects. Twenty-six healthy older adults (8 SN+ aged 58 ± 8 years, 18 SN− aged 57 ± 6 years) were asked to grip and lift a light-weight object with the dominant hand. Horizontal grip force, vertical lift force, acceleration, and first dorsal interosseus EMG were recorded during three trials. During the first trial, SN+ subjects exhibited a longer period between grip onset and lift onset (i.e. preload duration; 0.27 ± 0.25 s) than SN− subjects (0.13 ± 0.08 s; P = 0.046). They also exerted a greater downward force prior to lift off (−0.54 ± 0.42 N vs. −0.21 ± 0.12 N; P = 0.005) and used a greater grip force to lift the object (19.5 ± 7.0 N vs. 14.0 ± 4.3 N; P = 0.022) than SN− subjects. No between group differences were observed in subsequent trials. SN+ subjects exhibit impaired planning for manipulation of new objects. SN+ individuals over-estimate the grip force required, despite a longer contact period prior to lifting the object. The pattern of impairment observed in SN+ subjects shares similarities with de novo Parkinson’s disease patients.


  • Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene

    by Katja Lohmann, Robert A. Wilcox, Susen Winkler, Alfredo Ramirez, Aleksandar Rakovic, Jin‐Sung Park, Björn Arns, Thora Lohnau, Justus Groen, Meike Kasten, et al.

    Objective: A study was undertaken to identify the gene underlying DYT4 dystonia, a dominantly inherited form of spasmodic dysphonia combined with other focal or generalized dystonia and a characteristic facies and body habitus, in an Australian family.Methods: Genome‐wide linkage analysis was carried out in 14 family members followed by genome sequencing in 2 individuals. The index patient underwent a detailed neurological follow‐up examination, including electrophysiological studies and magnetic resonance imaging scanning. Biopsies of the skin and olfactory mucosa were obtained, and expression levels of TUBB4 mRNA were determined by quantitative real‐time polymerase chain reaction in 3 different cell types. All exons of TUBB4 were screened for mutations in 394 unrelated dystonia patients.Results: The disease‐causing gene was mapped to a 23cM region on chromosome 19p13.3‐p13.2 with a maximum multipoint LOD score of 5.338 at markers D9S427 and D9S1034. Genome sequencing revealed a missense variant in the TUBB4 (tubulin beta‐4; Arg2Gly) gene as the likely cause of disease. Sequencing of TUBB4 in 394 unrelated dystonia patients revealed another missense variant (Ala271Thr) in a familial case of segmental dystonia with spasmodic dysphonia. mRNA expression studies demonstrated significantly reduced levels of mutant TUBB4 mRNA in different cell types from a heterozygous Arg2Gly mutation carrier compared to controls.Interpretation: A mutation in TUBB4 causes DYT4 dystonia in this Australian family with so‐called whispering dysphonia, and other mutations in TUBB4 may contribute to spasmodic dysphonia. Given that TUBB4 is a neuronally expressed tubulin, our results imply abnormal microtubule function as a novel mechanism in the pathophysiology of dystonia. Ann Neurol 2013;73:537–545